Trifluridine/Tipiracil + Oxaliplatin · Advanced or Metastatic Biliary Tract Cancer
Recruitment suspended
Case Comprehensive Cancer CenterPhase 2 NCT07146646 Registry history of NCT07146646 on ClinicalTrials.gov (opens the registry)
10 trials changed in the last 30 days: 2 stopped, 3 with notable changes, 5 with minor changes only.
Recruitment suspended
Case Comprehensive Cancer CenterPhase 2 NCT07146646 Registry history of NCT07146646 on ClinicalTrials.gov (opens the registry)
Trial status changed: Recruiting → Withdrawn
Case Comprehensive Cancer CenterPhase 2 NCT06290687 Registry history of NCT06290687 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 2026 to Feb 20, 2028
Also in this update: Study completion pushed from Dec 2026 to Dec 1, 2029
Case Comprehensive Cancer CenterPhase 2 NCT06738303 Registry history of NCT06738303 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2027
Case Comprehensive Cancer CenterPhase 2 NCT06084780 Registry history of NCT06084780 on ClinicalTrials.gov (opens the registry)
Recruitment resumed after suspension
Case Comprehensive Cancer CenterNot applicable NCT06421155 Registry history of NCT06421155 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Jan 2027
Also in this update: Study completion pushed from Sep 2026 to Sep 2027
Case Comprehensive Cancer CenterNot applicable NCT06101069 Registry history of NCT06101069 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 27 participants (planned 36); Study completion date changed from estimate of Oct 30, 2026 to Apr 4, 2023
Case Comprehensive Cancer CenterPhase 1 NCT03535350 Registry history of NCT03535350 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Jan 2027
Also in this update: Study completion pushed from Sep 2026 to Sep 2027
Case Comprehensive Cancer CenterPhase 1/2 NCT01891318 Registry history of NCT01891318 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 2026 to Dec 2026
Case Comprehensive Cancer CenterPhase 2 NCT07104630 Registry history of NCT07104630 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 2026 to Dec 2026
Case Comprehensive Cancer CenterNot applicable NCT07060261 Registry history of NCT07060261 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07876986 Feasibility and Effectiveness of Sentinel Lymph Node Biopsy in Inflammatory Breast Cancer | Not Yet Recruiting | |
| 2026-09-22 | NCT07834281 High-concentration Capsaicin Patch for the Prevention of Paclitaxel-induced Peripheral… | Phase 4 | Not Yet Recruiting |
| Early Phase 1 | 1 | |
| Phase 1 | 8 | |
| Phase 1/2 | 2 | |
| Phase 2 | 14 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
Breast Cancer (9) · Prostate Cancer (8) · Colorectal Cancer (6) · Pancreatic Cancer (6) · Glioma (4) · Acute Myeloid Leukemia (AML) (3) · Esophageal Cancer (3) · Glioblastoma (3) · Leukemia (3) · Liver Cancer (3)